Related articles

Surgery is complete and the tumour has been removed —
many believe the hardest part is over.
But for most patients, the real challenge begins in the postoperative phase:
How to heal wounds faster? When will fatigue finally lift?
How to monitor recurrence risk? Can quality of life return to normal?

When cancer treatment — especially haematological malignancies, bone-marrow transplantation, long-term corticosteroids, or rituximab —
drives the immune system into “low-battery mode”,
the most common consequences are:
colds that drag on for weeks, recurrent pneumonia, shingles covering half the body, wounds that refuse to heal…

oral mucosa shredded, swallowing feels like broken glass, taste disappears, weight drops 1–2 kg per week…
The sentence we hear most often is:
“I know I need protein, but I physically can’t eat or swallow anything.”

Virtually every patient on androgen-deprivation therapy (ADT) faces progressive bone loss:
on average 4–7 % per year of treatment,
with fracture risk rising 2- to 5-fold within five years.
A single hip or vertebral fracture can dramatically affect quality of life and prognosis.

For patients on prolonged parenteral nutrition (TPN) — after pancreatic/gastric surgery, short-bowel syndrome, severe Crohn’s disease, or radiation enteritis —
zinc is one of the most easily overlooked yet critically important trace elements.
Only a few milligrams are needed daily, but zinc is involved in over 300 enzymes, wound healing, taste, immunity, and intestinal mucosal repair.
When it is lacking, the body falls into a vicious cycle: wounds won’t close, taste disappears, infections linger, and recovery stalls.

After major pancreatic or gastric surgery (Whipple, distal pancreatectomy, total gastrectomy),
the most common and distressing issues are almost always the same:
feeling full after a few bites, bloating, rapid weight loss, and persistent weakness.
This is not a lack of effort — the digestive system simply cannot absorb enough calories and nutrients in the usual way.

Turning “exhausted all day yet unable to sleep” into steady energy and restful nights
Cancer-related fatigue (CRF) is one of the deepest and most unspoken burdens for the majority of patients.
It is not ordinary tiredness — it is the result of disrupted mitochondrial function, elevated oxidative stress, and persistent low-grade inflammation caused by cancer and its treatments.
Numerous international studies have shown that high-dose intravenous vitamin C (IVC) is one of the safest and most widely recognised supportive options for managing CRF.